UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | G | H | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y | Z
Number of items: 92.


Adams, VC; Hunt, JR; Rosa Brunet, L; Rook, GAW; (2002) Effect of Mycobacterium vaccae on ICOS expression in a murine model. Presented at: UNSPECIFIED.

Ahn, JW; Powell, KL; Kellam, P; Alba, MM; (2002) Gammaherpesvirus lytic gene expression as characterised by DNA array. Journal of Virology , 76 (12) pp. 6244-6256.

Anand, A; Dean, GS; Quereshi, K; Isenberg, DA; Lydyard, PM; (2002) Characterisation of CD3+, CD4-, CD8- (double negative) T cells in patients with systemic lupus erythematosus (SLE): activation markers. Lupus , 11 pp. 493-500.

Andersson, J; Kinloch, S; Sonnerborg, A; Nilsson, J; Fehniger, TE; Spetz, AL; Behbahani, H; (2002) Low levels of perforin in CD8+ T lymphocytes in lymphoid tissue during acute human immunodeficiency virus type 1 infection. The Journal of Infectious Diseases , 185 pp. 1355-1358.


Boshoff, C; Weiss, RA; (2002) AIDS-related malignancies. Nature Reviews Cancer , 2 pp. 373-382.


Cepeda, JA; Hayman, SJ; Kibbler, C; Wilson, APR; (2002) In vitro susceptibility of Gram-positive cocci to linezolid and teicoplanin: twelve month use of linezolid for Gram-positive infections in ICU. Presented at: European Congress of Chemotherapy.

Cepeda, JA; Hayman, SJ; Kibbler, C; Wilson, APR; (2002) In vitro susceptibility of Gram-positive cocci to linezolid and teicoplanin: use of linezolid for Gram-positive infections in ICU. Presented at: UNSPECIFIED.

Cepeda, JA; Whitehouse, T; Cooper, B; Hails, J; Hayman, SJ; Jones, K; Kwaku, F; (2002) Linezolid versus teicoplanin in the treatment of Gram positive infections in the critically ill: a randomized, double-blind, multicentre study. Presented at: 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).

Cepeda, JA; Whitehouse, T; Tobin, C; Zhang, J; MacGowan, A; Kibbler, C; Shaw, S; (2002) The Pharmacokinetic Profiles of Linezolid and Teicoplanin in the critically ill. Presented at: UNSPECIFIED.

Cepeda, JA; Whitehouse, T; Tobin, C; Zhang, J; MacGowan, A; Kibbler, C; Shaw, S; (2002) The Pharmacokinetic Profiles of Linezolid and Teicoplanin in the critically ill. Presented at: European Congress of Chemotherapy.

Cepeda, JA; Whitehouse, T; Wilson, APR; Singer, M; Bellingan, G; Kibbler, C; Shaw, S; (2002) MRSA clearance during treatment with linezolid. Presented at: European Congress of Chemotherapy.

Cochrane, A; Searle, B; Hardie, A; Robertson, R; Delahooke, T; Cameron, S; Tedder, RS; (2002) A genetic analysis of hepatitis Cvirus transmission between injection drug users. JOURNAL OF INFECTIOUS DISEASES , 186 (9) 1212 - 1221.

Cooke, FJ; Sabin, CA; Zuckerman, JN; (2002) Impact of the insect biting nuisance on a British youth expedition to Alaska. J TRAVEL MED , 9 (2) 76 - 81.


Davies, K; Woo, P; (2002) Immunisation in rheumatic diseases of childhood: an audit of the clinical practice of BPRG members and a review of the evidence. Rheumatology , 41 pp. 937-941.

Davies, K; Woo, P; British Paediatric Rheumatology Group, ; (2002) Immunization in rheumatic diseases of childhood: an audit of the clinical practice of British Paediatric Rheumatology Group members and a review of the evidence. Rheumatology (Oxford) , 41 (8) pp. 937-941.

Dimmic, MW; Rest, JS; Mindell, DP; Goldstein, RA; (2002) rtREV: an amino acid substitution matrix for inference of retrovirus and reverse transcriptase phylogeny. J Mol Evol , 55 (1) pp. 65-73. 10.1007/s00239-001-2304-y.

Donoghue, HD; Marcik, A; Matheson, C; Vernon, K; Spigelman, M; (2002) Co-infection of Mycobacterium tuberculosis and Mycobacterium leprae in archaeological specimens. Presented at: 6th International Conference of Ancient DNA and Associated Biomolecules, Tel Aviv, Israel.


Garson, J; Aggarwal, A; Sarkar, S; (2002) Birds as surrogates for biodiversity: an analysis of a data set from southern Quebec. J.Biosci. , 27 (4 Supp) pp. 347-360.

Gibson, S; Greenblatt, C; Spigelman, M; Gorski, A; Donoghue, HD; Vernon, K; Matheson, CD; (2002) The Shroud Cave - a unique case study linking a closed loculus, a shroud and ancient mycobacteria. Presented at: 6th International Conference of Ancient DNA and Associated Biomolecules, Tel Aviv, Israel.

Gilbert, N; Corden, S; Ijaz, S; Grant, PR; Tedder, RS; Boxall, EH; (2002) Comparison of commercial assays for the quantification of HBV DNA load in health care workers: calibration differences. J VIROL METHODS , 100 (1-2) 37 - 47.

Gillespie, SH; Billington, OJ; Breathnach, A; McHugh, TD; (2002) Multiple drug resistant tuberculosis: evidence for changing fitness on passage through human hosts. Microbial Drug Resistance , 8 pp. 1-7.

Griffiths, PD; (2002) Benefits of bioterrorism. Reviews In Medical Virology , 12 (3) pp. 131-132.

Griffiths, PD; (2002) Interactions between viral and human genes. Reviews In Medical Virology , 12 (4) pp. 197-199.

Griffiths, PD; (2002) Preparing to treat prions. Reviews In Medical Virology , 12 (1) pp. 1-3.


Harrison, OB; Robertson, BD; Faust, SN; Jepson, MA; Goldin, RD; Levin, M; Heyderman, RS; (2002) Analysis of pathogen-host cell interactions in purpura fulminans: expression of capsule, type IV pili, and PorA by Neisseria meningitidis in vivo. Infect Immun , 70 (9) pp. 5193-5201.

Hopkins, S; Hennessy, M; Lyons, F; Mulachy, F; Bergin, C; (2002) Treatment of chronic Hepatitis C with pegylated interferon and ribavirin in HIV co-infected patients. In: HEPATOLOGY. (pp. 231A - 231A).

Huggett, JF; Mustafa, A; O'Neil, L; Mason, DJ; (2002) Does osteogenesis differentially regulate GLAST-1 and GLAST-1a? Presented at: UNSPECIFIED.


Jabs, DA; Griffiths, PD; (2002) Fomivirsen for the treatment of cytomegalovirus retinitis. AM J OPHTHALMOL , 133 (4) 552 - 556.


Jolles, S; Downey, J; Buxton, RS; (2002) DNA microarrays. CPD Bulletin Immunology and Allergy , 2 (3) pp. 84-88.


Kellam, P; AlbÃ, MM; (2002) Virus bioinformatics: databases and recent applications. Applied Bioinformatics , 1 (1) pp. 37-42.

Kellam, P; Mar Alba, M; (2002) Databases and recent applications. Applied Bioinformatics , 1 (1) pp. 37-42.

Kellam, P; Xiaohui, L; Martin, NJ; Orengo, CA; Swift, S; Tucker, A; (2002) A framework for modelling virus gene expression data. Intelligent Data Analysis , 5 pp. 1-13.

Kinloch, SA; B, ; (2002) HIV-1 therapeutic vaccines. Journal of INfection , 44 pp. 152-159.

Kumon, Y; Suehiro, T; Faulkes, DJ; Hosakawa, T; Ikeda, Y; Woo, P; Sipe, JD; (2002) Transcriptional regulation of serum amyloid A1 gene expression in human aortic smooth muscle cells involves CCAAT/enhancer binding proteins (C/EBP) and is distinct from HepG2 cells. SCAND J IMMUNOL , 56 (5) 504 - 511.


Lev-Maor, G; Blondiaux, J; Spigelman, M; Donoghue, H; Rothschild, B; Zias, J; Kahila, G; (2002) Ancient tuberculosis: problems of diagnosis and characterization. Presented at: 6th International Conference of Ancient DNA and Associated Biomolecules, Tel Aviv, Israel.

Lilley, CE; Coffin, RS; (2002) Herpes simplex virus vectors. In: Machida, CE, (ed.) Virus vectors for gene therapy: methods and protocols. (pp. 33-50). Humana Press: New York.

Lord, JM; Akbar, AN; Kipling, D; (2002) Telomere-based therapy for immunosenescence. Trends Immunol , 23 (4) pp. 175-176.


Maini, MK; Bertoletti, A; (2002) Cytokines in viral hepatitis. In: Kobt, M and Calandra, T, (eds.) Cytokines and chemokines in infectious diseases. (pp. 355-375). Humana Press

Manzotti, CN; Tipping, H; Perry, LC; Mead, KI; Blair, PJ; Zheng, Y; Sansom, DM; (2002) Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells. Eur J Immunol , 32 (10) pp. 2888-2896. 10.1002/1521-4141(2002010)32:10<2888::AID-IMMU2888>3.0.CO;2-F.

Mason, DJ; Huggett, JF; (2002) Glutamate transporters in bone. Journal of Musculoskeletal and Neuronal Interactions , 2 (5) pp. 406-414.

McGregor, JM; Harwood, CA; Brooks, L; Fisher, SA; Kelly, DA; O'nions, J; Young, AR; (2002) Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer. J INVEST DERMATOL , 119 (1) 84 - 90.

Messina, CG; Reeves, EP; Roes, J; Segal, AW; (2002) Catalase negative Staphylococcus aureus retain virulence in mouse model of chronic granulomatous disease. FEBS Letters , 518 (1-3) pp. 107-110.

Mitchison, NA; Roes, JT; (2002) Patterned variation in murine MHC promoters. Proceedings of the National Academy of Sciences of the United States of America , 99 (16) pp. 10561-10566. 10.1073/pnas.152329999.

Morgan, JE; Gross, JG; Pagel, CN; Beauchamp, JR; Fassati, A; Thrasher, AJ; Di Santo, JP; (2002) Myogenic cell proliferation and generation of a reversible tumorigenic phenotype are triggered by preirradiation of the recipient site. J CELL BIOL , 157 (4) 693 - 702. 10.1083/jcb.200108047.

Muir, WB; Nichols, R; Breuer, J; (2002) Phylogenetic analysis of varicella-zoster virus: Evidence of intercontinental spread of genotypes and recombination. J VIROL , 76 (4) 1971 - 1979. 10.1128/JVI.76.4.1971-1979.2002.


Nothdurft, HD; Dietrich, M; Zuckerman, JN; Knobloch, J; Kern, P; Vollmar, J; Sanger, R; (2002) A new accelerated vaccination schedule for rapid protection against hepatitis A and B. VACCINE , 20 (7-8) 1157 - 1162.


Ortego, J; Escors, D; Laude, H; Enjuanes, L; (2002) Generation of a replication-competent, propagation-deficient virus vector based on the transmissible gastroenteritis coronavirus genome. J VIROL , 76 (22) 11518 - 11529. 10.1128/JVI.76.22.11518-11529.2002.

Ota, MO; Vekemans, J; Schlegel-Haueter, SE; Fielding, K; Sanneh, M; Kidd, M; Newport, MJ; (2002) Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination. J Immunol , 168 (2) pp. 919-925.


Palmer, JA; Coffin, RS; (2002) Target validation in the nervous system using herpes simplex viral vectors. European Pharmaceutical Review , Winter pp. 64-70.

Peggs, KS; Morris, EC; Kottaridis, PD; Geary, J; Goldstone, AH; Linch, DC; Mackinnon, S; (2002) Conditioning regimen may influence outcome of ABO incompatible non-myeloablative haemtopoietic allogeneic stem cell transplantation. Blood , 99 pp. 4642-4644.

Perrin, L; Cooper, DA; Hoen, B; Kinloch, S; Phillips, A; Tsoukas, C; Andersson, J; (2002) Therapeutic vaccination in primary HIV infection, the Quest trial. Vaccine , 20 (15) pp. 2004-2006. 10.1016/S0264-410X(02)00087-7.

Pers, JO; Berthou, C; Porakishvili, N; Burjanadze, M; Le Calvez, G; Abgrall, JF; Lydyard, PM; (2002) CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia. Leukemia , 16 (1) pp. 44-52.

Pers, JO; Jamin, C; Lydyard, PM; Charriere, J; Youinou, P; (2002) The H2 haplotype regulates the distribution of B cells into B-1a, B-1b and B-2 subsets. Immunogenetics , 54 (3) pp. 208-211.

Porakishvili, N; Jewell, AP; Kwee, Y; Akbar, A; Lydyard, PM; (2002) CD4+PF+ T cells with regulatory phenotype in B cell chronic lymphocytic leukaemia (B-CLL). In: BLOOD. (pp. 356B - 356B).


Qian, B; Goldstein, RA; (2002) Optimization of a new score function for the generation of accurate alignments. Proteins , 48 (4) pp. 605-610. 10.1002/prot.10132.

Quinlivan, M; Hawrami, K; Barrett-Muir, W; Aaby, P; Arvin, A; Chow, VT; John, TJ; (2002) The molecular epidemiology of varicella-zoster virus: Evidence for geographic segregation. JOURNAL OF INFECTIOUS DISEASES , 186 (7) 888 - 894.


Reignat, S; Webster, GJM; Brown, D; Ogg, GS; King, A; Seneviratne, SL; Dusheiko, G; (2002) Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J EXP MED , 195 (9) 1089 - 1101. 10.1084/jem.20011723.

Rook, GA; Lightman, SL; Heijnen, CJ; (2002) Can nerve damage disrupt neuroendocrine immune homeostasis? Leprosy as a case in point. Trends in Immunology , 23 (1) pp. 18-22.

Rook, GAW; (2002) Immunoregulation: the hygiene hypothesis and the brain. In: Immunology. (pp. 40 - 40).

Rook, GAW; Rosa Brunet, L; Hunt, J; (2002) Multiple consequences of the changing educational input to our immune systems. In: Heidt, PJ and Midtvedt, T and Rusch, V and van der Waaij, D, (eds.) Probiotics: Bacteria and Bacterial Fragments as Immunomodulatory Agents. (pp. 35-53). Institut f+r Integrative Biologie GmbH: Herborn-Dill, Germany.


Sadiq, ST; Taylor, S; Kaye, S; Bennett, J; Johnstone, R; Byrne, P; Copas, AJ; (2002) The effects of antirectroviral therapy on HIV-1 RNA loads in seminal plasma in HIV positive patients with and without urethritis. AIDS , 16 (2) pp. 219-255. 10.1097/00002030-200201250-00011.

Schofield, JN; Stephens, JW; Hurel, SJ; Bell, KM; deSouza, JB; Rademacher, TW; (2002) Insulin reduces serum glycosylphosphatidylinositol phospholipase D levels in human type 1 diabetic patients and streptozotocin diabetic rats. Molecular Genetics and Metabolism , 2 (154) 161-.

Simmonds, P; Kurtz, J; Tedder, RS; (2002) The UK blood transfusion service: over a (patent) barrel? The Lancet , 359 (9319) pp. 1713-1714.

Spigelman, M; Fletcher, HA; Pap, I; Donoghue, HD; (2002) The Hungarian Mummy Study 2002: Progress since DNA5 - Distribution and characteristics of Mycobacterium tuberculosis DNA in 18th century human remains. Presented at: 6th International Conference of Ancient DNA and Associated Biomolecules, Tel Aviv, Israel.

Spigelman, M; Matheson, C; Lev, G; Greenbaltt, C; Donoghue, HD; (2002) Confirmation of the presence of Mycobacterium-tuberculosis complex-specific DNA in three archaeological specimens. INT J OSTEOARCHAEOL , 12 (6) 393 - 401. Green open access

Stringer, C; Chiodini, J; Zuckerman, JN; (2002) Continuing Professional Development in Travel Medicine. The Nursing Standard , 16 (39) pp. 49-54.


Taverna, DM; Goldstein, RA; (2002) Why are proteins so robust to site mutations? J Mol Biol , 315 (3) pp. 479-484. 10.1006/jmbi.2001.5226.

Temperton, NJ; (2002) DNA vaccines against cytomegalovirus: current progress. International Journal of Antimicrobial Agents , 19 (3) pp. 169-172.

Thomas, SK; Lilley, CE; Latchman, DS; Coffin, RS; (2002) A protein encoded by the herpes simplex virus (HSV) type 1 2-kilobase latency-associated transcript is phosphorylated, localized to the nucleus, and overcomes the repression of expression from exogenous promoters when inserted into the quiescent HSV genome. J VIROL , 76 (8) 4056 - 4067. 10.1128/JVI.76.8.4056-4067.2002.

Thomson, W; Barrett, JH; Donn, R; Pepper, L; Kennedy, LJ; Ollier, WE; Silman, AJ; (2002) Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients. Rheumatology (Oxford) , 41 (10) pp. 1183-1189.

Toellner, KM; Jenkinson, WE; Taylor, DR; Khan, M; Sze, DM; Sansom, DM; Vinuesa, CG; (2002) Low-level hypermutation in T cell-independent germinal centers compared with high mutation rates associated with T cell-dependent germinal centers. J Exp Med , 195 (3) pp. 383-389.


Vekemans, J; Ota, MO; Wang, EC; Kidd, M; Borysiewicz, LK; Whittle, H; McAdam, KP; (2002) T cell responses to vaccines in infants: defective IFNgamma production after oral polio vaccination. Clin Exp Immunol , 127 (3) pp. 495-498.


Walker, SJ; Pizzato, M; Takeuchi, Y; Devereux, S; (2002) Heparin binds to murine leukaemia virus and inhibits Env-independent attachment and infection. Journal of Virology , 76 pp. 6909-6918.

Wedderburn, LR; Patel, A; Woo, P; (2002) Direct visualisation of the cytokine driven synovial T cell response in juvenile idiopathic arthritis. Presented at: UNSPECIFIED.

Weiss, RA; (2002) HIV receptors and cellular tropism. IUBMB LIFE , 53 (4-5) 201 - 205. 10.1080/15216540290098927.

Weiss, RA; (2002) Reflections on the origin of human immunodeficiency viruses. AIDS and Hepatitis Digest , 87 pp. 2-4.

Weiss, RA; (2002) Xenotransplantation: promise and problems. In: Brooks, G, (ed.) Gene Therapy: the use of DNA as a drug. (pp. 295-312). Pharmaceutical Press

Whitehouse, T; Cepeda, J; Cooper, B; Hails, J; Jones, K; Kwaku, F; Taylor, L; (2002) Treatment of bacteraemia and LRTI with linezolid in the critically ill patient: a randomized double-blind comparison against teicoplanin. Presented at: 15th Annual Congress of the European Society of Intensive Care Medicine..

Wilkinson, J; Cope, A; Gill, J; Bourboulia, D; Hayes, P; Imami, N; Kubo, T; (2002) Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-infected patients receiving highly active antiretr. Journal of Virology , 76 (6) pp. 2634-2640.

Williams, RJ; Henderson, B; Sharp, LJ; Nair, SP; (2002) Identification of a fibronectin-binding protein from Staphylococcus epidermidis. INFECT IMMUN , 70 (12) 6805 - 6810. 10.1128/IAI.70.12.6805-6810.2002.


Yang, TH; Lovatt, M; Merkenschlager, M; Stauss, HJ; (2002) Comparison of the freqency of peptide-specific CTL restricted by self and allo-MHC following in vitro T cell priming. International Immunology , 14 (11) pp. 1283-1290.

Youinou, P; Lydyard, PM; Mageed, RA; (2002) B cells underpin lupus immuno-pathology. Lupus , 11 (1) pp. 1-3.

Yuan, B; Fassati, A; Yueh, A; Goff, SP; (2002) Characterization of Moloney murine leukemia virus p12 mutants blocked during early events of infection. J VIROL , 76 (21) 10801 - 10810. 10.1128/JVI.76.21.10801-10810.2002.


Zuckerman, J; (2002) Recent Advances in Travel Medicine. BMJ (Clinical Research Ed.) , 325 pp. 260-264.

Zuckerman, JN; (2002) Clinical Review: Recent Advances in Travel Medicine. BMJ (Clinical Research Ed.) , 325 pp. 260-264.

Zuckerman, JN; (2002) Health and illness among airline passengers. In: Bor, R, (ed.) Passenger Behaviour. (pp. 232-246). Ashgate Publishing

Zuckerman, JN; (2002) Travel health advice for travellers with immunosuppressive disorders. In: Howarth-Wilson, J, (ed.) Bugs, Bowels & Bites. Cadogan Guides

Zuckerman, JN; (2002) A guide to the medical student elective abroad. In: Ryan, J and Greaves, I and Mahoney, P and Bowyer, G, (eds.) Handbook of Medicine in Hostile Environments. (pp. 131-141). Springer-Verlag London

Zuckerman, JN; (2002) International Travel and Health 2002. In: World, HO, (ed.) International Travel and Health 2002. (pp. 1-210). World Health Organisation

Zuckerman, JN; Zuckerman, AJ; (2002) Viral hepatitis. In: Dawood, R, (ed.) Travellers' Health. (pp. 54-62). Oxford University Press

Zuckerman, JN; Zuckerman, AJ; (2002) Molecular Epidemiology of Hepatitis B virus. In: Leitner, T, (ed.) The Molecualr Epidemiology of Human Viruses. (pp. 401-419). Kluwer Academic Publishers

This list was generated on Sun Sep 25 08:49:54 2016 BST.